1,102
Views
65
CrossRef citations to date
0
Altmetric
Review Article

Considerations in the use of microneedles: pain, convenience, anxiety and safety

, , &
Pages 29-40 | Received 06 Mar 2016, Accepted 08 Jun 2016, Published online: 30 Jun 2016

References

  • Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol 2008;26:1261–8.
  • Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 2004;3:115–24.
  • Henry S, McAllister DV, Allen MG, et al. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci 1998;87:922–5.
  • McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles for gene and drug delivery. Annu Rev Biomed Eng 2000;2:289–313.
  • Kim Y-C, Park J-H, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 2012;64:1547–68.
  • Donnelly RF, Singh TRR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv 2010;17:187–207.
  • Lee JW, Han M-R, Park J-H. Polymer microneedles for transdermal drug delivery. J Drug Target 2013;21:211–23.
  • Pierre M, Rossetti F. Microneedle-based drug delivery systems for transdermal route. Curr Drug Targets 2014;15:281–91.
  • Bachy V, Hervouet C, Becker PD, et al. Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays. Proc Natl Acad Sci USA 2013;110:3041–6.
  • Edens C, Collins ML, Goodson JL, et al. A microneedle patch containing measles vaccine is immunogenic in non-human primates. Vaccine 2015;33:4712–18.
  • Chu LY, Ye L, Dong K, et al. Enhanced stability of inactivated influenza vaccine encapsulated in dissolving microneedle patches. Pharm Res 2016;33:868–78.
  • Edens C, Dybdahl-Sissoko NC, Weldon WC, et al. Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque. Vaccine 2015;33:4683–90.
  • Baek C, Han M, Min J, et al. Local transdermal delivery of phenylephrine to the anal sphincter muscle using microneedles. J Control Release 2011;154:138–47.
  • Jun H, Han M-R, Kang N-G, et al. Use of hollow microneedles for targeted delivery of phenylephrine to treat fecal incontinence. J Control Release 2015;207:1–6.
  • Rai UDJ, Young SA, Thrimawithana TR, et al. The suprachoroidal pathway: a new drug delivery route to the back of the eye. Drug Discov Today 2015;20:491–5.
  • Song HB, Lee KJ, Seo IH, et al. Impact insertion of transfer-molded microneedle for localized and minimally invasive ocular drug delivery. J Control Release 2015;209:272–9.
  • Yang S, Wu F, Liu J, et al. Phase‐transition microneedle patches for efficient and accurate transdermal delivery of insulin. Adv Funct Mater 2015;25:4633–41.
  • Liu S, Wu D, Quan Y-s, et al. Improvement of transdermal delivery of exendin-4 using novel tip-loaded microneedle arrays fabricated from hyaluronic acid. Mol Pharm 2015;13:272–9.
  • Kolli CS. Microneedles: bench to bedside. Ther Deliv 2015;6:1081–8.
  • Brogden NK, Banks SL, Crofford LJ, et al. Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans. Pharm Res 2013;30:1947–55.
  • Donnelly RF, Moffatt K, Alkilani AZ, et al. Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet. Pharm Res 2014;31:1989–99.
  • Zhao X, Birchall JC, Coulman SA, et al. Microneedle delivery of autoantigen for immunotherapy in type 1 diabetes. J Control Release 2016;223:178–87.
  • Torrisi BM, Zarnitsyn V, Prausnitz M, et al. Pocketed microneedles for rapid delivery of a liquid-state botulinum toxin A formulation into human skin. J Control Release 2013;165:146–52.
  • Hirobe S, Azukizawa H, Hanafusa T, et al. Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch. Biomaterials 2015;57:50–8.
  • Kim M, Yang H, Kim H, et al. Novel cosmetic patches for wrinkle improvement: retinyl retinoate- and ascorbic acid-loaded dissolving microneedles. Int J Cosmet Sci 2014;36:207–12.
  • Noh Y-W, Kim T-H, Baek J-S, et al. In vitro characterization of the invasiveness of polymer microneedle against skin. Int J Pharm 2010;397:201–5.
  • Norman JJ, Brown MR, Raviele NA, et al. Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes. Pediatr Diabetes 2013;14:459–65.
  • Blount RL, Piira T, Cohen LL, et al. Pediatric procedural pain. Behav Modif 2006;30:24–49.
  • Gupta J, Felner EI, Prausnitz MR. Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. Diabetes Technol Ther 2009;11:329–37.
  • Hassan R. Comparison of efficacy of micro needling for the treatment of acne scars in Asian skin with and without subcision. J Turk Acad Dermatol 2015;9:159–66.
  • Park J-H, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release 2005;104:51–66.
  • Gittard SD, Ovsianikov A, Monteiro-Riviere NA, et al. Fabrication of polymer microneedles using a two-photon polymerization and micromolding process. J Diabetes Sci Technol 2009;3:304–11.
  • Coulman SA, Anstey A, Gateley C, et al. Microneedle mediated delivery of nanoparticles into human skin. Int J Pharm 2009;366:190–200.
  • Kusamori K, Katsumi H, Sakai R, et al. Development of a drug-coated microneedle array and its application for transdermal delivery of interferon alpha. Biofabrication 2016;8:015006.
  • van der Maaden K, Luttge R, Vos PJ, et al. Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays. Drug Deliv Transl Res 2015;5:397–406.
  • Gill HS, Prausnitz MR. Coated microneedles for transdermal delivery. J Control Release 2007;117:227–37.
  • Vrdoljak A, McGrath MG, Carey JB, et al. Coated microneedle arrays for transcutaneous delivery of live virus vaccines. J Control Release 2012;159:34–42.
  • Daddona PE, Matriano JA, Mandema J, et al. Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm Res 2011;28:159–65.
  • Ma Y, Tao W, Krebs SJ, et al. Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity. Pharm Res 2014;31:2393–403.
  • Zaric M, Lyubomska O, Poux C, et al. Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and Th1 immune responses by murine langerhans cells. J Invest Dermatol 2015;135:425–34.
  • Lahiji SF, Dangol M, Jung H. A patchless dissolving microneedle delivery system enabling rapid and efficient transdermal drug delivery. Sci Rep 2015;5:7914. doi: 10.1038/srep07914.
  • Sullivan SP, Koutsonanos DG, del Pilar Martin M, et al. Dissolving polymer microneedle patches for influenza vaccination. Nat Med 2010;16:915–20.
  • Lee JW, Choi SO, Felner EI, et al. Dissolving microneedle patch for transdermal delivery of human growth hormone. Small 2011;7:531–9.
  • Fukushima K, Ise A, Morita H, et al. Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats. Pharm Res 2011;28:7–21.
  • Marshall S, Sahm LJ, Moore AC. Microneedle technology for immunisation: perception, acceptability and suitability for paediatric use. Vaccine 2016;34:723–34.
  • Patel SR, Lin AS, Edelhauser HF, et al. Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res 2011;28:166–76.
  • Norman JJ, Gupta J, Patel SR, et al. Reliability and accuracy of intradermal injection by Mantoux technique, hypodermic needle adapter, and hollow microneedle in pigs. Drug Deliv Trans Res 2014;4:126–30.
  • Ma Y, Tao W, Krebs SJ, et al. Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity. Pharm Res 2014;31:2393–403.
  • Zhu J, Shen Q, Cao Y, et al. The fabrication and property of a novel coated out-of-plane microneedle arrays. Microsyst Technol 2016;22:143–9.
  • Chen J, Qiu Y, Zhang S, et al. Controllable coating of microneedles for transdermal drug delivery. Drug Dev Ind Pharm 2015;41:415–22.
  • Lee K, Lee CY, Jung H. Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose. Biomaterials 2011;32:3134–40.
  • Vassilieva EV, Kalluri H, McAllister D, et al. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature. Drug Deliv Trans Res 2015;5:360–71.
  • Wu D, Katsumi H, Quan Y-S, et al. Permeation of sumatriptan succinate across human skin using multiple types of self-dissolving microneedle arrays fabricated from sodium hyaluronate. J Drug Target 2016;24:752–8.
  • Li CG, Joung H-A, Noh H, et al. One-touch-activated blood multidiagnostic system using a minimally invasive hollow microneedle integrated with a paper-based sensor. Lab Chip 2015;15:3286–92.
  • Le Thanh H, Ta BQ, Le The H, et al. Low-cost fabrication of hollow microneedle arrays using CNC machining and UV lithography. J Microelectromech S 2015;24:1583–93.
  • Sivamani RK, Stoeber B, Wu GC, et al. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration. Skin Res Technol 2005;11:152–6.
  • Kleinknecht RA, Thorndike RM, Walls MM. Factorial dimensions and correlates of blood, injury, injection and related medical fears: cross validation of the Medical Fear Survey. Behav Res Ther 1996;34:323–31.
  • Haq M, Smith E, John D, et al. Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdev 2009;11:35–47.
  • Gill HS, Prausnitz MR. Does needle size matter? J Diabetes Sci Technol 2007;1:725–9.
  • Gill HS, Denson DD, Burris BA, et al. Effect of microneedle design on pain in human volunteers. Clin J Pain 2008;24:585.
  • Chernik DA, Gillings D, Laine H, et al. Validity and Reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol 1990;10:244–51.
  • Gupta J, Park SS, Bondy B, et al. Infusion pressure and pain during microneedle injection into skin of human subjects. Biomaterials 2011;32:6823–31.
  • Gupta J, Gill HS, Andrews SN, et al. Kinetics of skin resealing after insertion of microneedles in human subjects. J Control Release 2011;154:148–55.
  • Sezgin B, Ozel B, Bulam H, et al. The effect of microneedle thickness on pain during minimally invasive facial procedures: a clinical study. Aesthet Surg J 2014;34:757–65.
  • Aoyagi S, Izumi H, Fukuda M. Biodegradable polymer needle with various tip angles and effect of vibration and surface tension on easy insertion. In: IEEE 20th International Conference on Micro Electro Mechanical Systems (MEMS); 2007.
  • Martanto W, Moore JS, Kashlan O, et al. Microinfusion using hollow microneedles. Pharm Res 2006;23:104–13.
  • Levick J. Flow through interstitium and other fibrous matrices. Q J Exp Physiol 1987;72:409–37.
  • Lee F-W, Hung W-H, Ma C-W, et al. Polymer-based disposable microneedle array with insertion assisted by vibrating motion. Biomicrofluidics 2016;10:011905.
  • Verbaan F, Bal S, Van den Berg D, et al. Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. J Control Release 2008;128:80–8.
  • Kettwich SC, Sibbitt WL, Brandt JR, et al. Needle phobia and stress-reducing medical devices in pediatric and adult chemotherapy patients. J Pediatr Oncol Nurs 2007;24:20–8.
  • Fassler D. The fear of needles in children. Am J Orthopsychiatry 1985;55:371.
  • Caffarel-Salvador E, Tuan-Mahmood T-M, McElnay JC, et al. Potential of hydrogel-forming and dissolving microneedles for use in paediatric populations. Int J Pharm 2015;489:158–69.
  • Mooney K, McElnay JC, Donnelly RF. Children's views on microneedle use as an alternative to blood sampling for patient monitoring. Int J Pharm Pract 2014;22:335–44.
  • Mooney K, McElnay JC, Donnelly RF. Paediatricians' opinions of microneedle-mediated monitoring: a key stage in the translation of microneedle technology from laboratory into clinical practice. Drug Deliv Transl Res 2015;5:346–59.
  • Chege M, McConville A, Davis J. Microneedle drug delivery systems: appraising opportunities for improving safety and assessing areas of concern. J Chem Health Saf 2016. [Epub ahead of print]. doi: 10.1016/j.jchas.2016.04.008.
  • Shah V, Taddio A, Rieder MJ, et al. Effectiveness and tolerability of pharmacologic and combined interventions for reducing injection pain during routine childhood immunizations: systematic review and meta-analyses. Clin Ther 2009;31:S104–51.
  • Bakshi P, Roy S, Sadhukhan S, et al. Painless microneedles for intradermal delivery of vaccines. J Adv Pharm Educ Res 2014;4:158–64.
  • Norman JJ, Arya JM, McClain MA, et al. Microneedle patches: usability and acceptability for self-vaccination against influenza. Vaccine 2014;32:1856–62.
  • Taddio A, Ipp M, Thivakaran S, et al. Survey of the prevalence of immunization non-compliance due to needle fears in children and adults. Vaccine 2012;30:4807–12.
  • Taddio A, Appleton M, Bortolussi R, et al. Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline. Can Med Assoc J 2010;182:E843–55.
  • Aoyagi S, Izumi H, Fukuda M. Biodegradable polymer needle with various tip angles and consideration on insertion mechanism of mosquito's proboscis. Sens Actuators A 2008;143:20–8.
  • Davis SP, Landis BJ, Adams ZH, et al. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J Biomech 2004;37:1155–63.
  • Palakurthi NK, Correa ZM, Augsburger JJ, et al. Toxicity of a biodegradable microneedle implant loaded with methotrexate as a sustained release device in normal rabbit eye: a pilot study. J Ocul Pharmacol Ther 2011;27:151–6.
  • Yuzhakov VV. The AdminPen™ microneedle device for painless & convenient drug delivery. Drug Deliv Technol 2010;10:32–6.
  • Bediz B, Korkmaz E, Khilwani R, et al. Dissolvable microneedle arrays for intradermal delivery of biologics: fabrication and application. Pharm Res 2014;31:117–35.
  • Park J-H, Prausnitz MR. Analysis of mechanical failure of polymer microneedles by axial force. J Korean Phys Soc 2010;56:1223.
  • Gittard SD, Chen B, Xu H, et al. The effects of geometry on skin penetration and failure of polymer microneedles. J Adhes Sci Technol 2013;27:227–43.
  • McKellop HA, Campbell P, Park S-H, et al. The origin of submicron polyethylene wear debris in total hip arthroplasty. Clin Orthop Relat Res 1995;311:3–20.
  • Betts F, Wright T, Salvati EA, et al. Cobalt-alloy metal debris in periarticular tissues from total hip revision arthroplasties: metal contents and associated histologic findings. Clin Orthop Relat Res 1992;276:75–82.
  • Food and Drug Administration; 2015. Available from: http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm429899.htm.
  • Raphael AP, Crichton ML, Falconer RJ, et al. Formulations for microprojection/microneedle vaccine delivery: structure, strength and release profiles. J Control Release 2016;225:40–52.
  • Bal SM, Caussin J, Pavel S, et al. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci 2008;35:193–202.
  • Kaushik S, Hord AH, Denson DD, et al. Lack of pain associated with microfabricated microneedles. Anesth Analg 2001;92:502–4.
  • Hoesly FJ, Borovicka J, Gordon J, et al. Safety of a novel microneedle device applied to facial skin: a subject- and rater-blinded, sham-controlled, randomized trial. Arch Dermatol 2012;148:711–17.
  • Donnelly RF, Singh TRR, Tunney MM, et al. Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm Res 2009;26:2513–22.
  • Gill HS, Prausnitz MR. Coating formulations for microneedles. Pharm Res 2007;24:1369–80.
  • Zhang Y, Brown K, Siebenaler K, et al. Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action. Pharm Res 2012;29:170–7.
  • Raymond C, Rowe PJS, Quinn ME. Handbook of pharmaceutical excipients; 2009:117–21.
  • Raymond C, Rowe PJS, Quinn ME. Handbook of pharmaceutical excipients. East Smithfield, London, UK: Pharnaceutical Press; 2009:703–6.
  • Jung HS, Kim KS, Yun SH, et al. Enhancing the transdermal penetration of nanoconstructs: could hyaluronic acid be the key? Nanomedicine (Lond) 2014;9:743–5.
  • Raymond C, Rowe PJS, Quinn ME. Handbook of pharmaceutical excipients; 2009:782–5.
  • Booth A, Hendrickson A, DeEds F. Physiologic effects of three microbial polysaccharides on rats. Toxicol Appl Pharmacol 1963;5:478–84.
  • Rajinikanth P, Sankar C, Mishra B. Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: development and evaluation. Drug Deliv 2003;10:21–8.
  • Nair B. Final report on the safety assessment of polyvinylpyrrolidone (PVP). Int J Toxicol 1998;17:95–130.
  • Lewis RJ. Dangerous properties of industrial materials. 11th ed. New York: Wiley; 2004.
  • Raymond C, Rowe PJS, Quinn ME. Handbook of pharmaceutical excipients; 2009:506–9.
  • Maryadele J. Merck index. 14th ed. Whitehouse Station, NJ: Merck Reasearch Laboratories. p. 7582.
  • Bhattacharjee J, Verma G, Aswal V, et al. Tween 80− sodium deoxycholate mixed micelles: structural characterization and application in doxorubicin delivery. J Phys Chem B 2010;114:16414–21.
  • Richards A, Krakowka S, Dexter L, et al. Trehalose: a review of properties, history of use and human tolerance, and results of multiple safety studies. Food Chem Toxicol 2002;40:871–98.
  • Quinn HL, Larrañeta E, Donnelly RF. Dissolving microneedles: safety considerations and future perspectives. Ther Deliv 2016;7:283–5.
  • Ohlson M, Sörensson J, Haraldsson B. Glomerular size and charge selectivity in the rat as revealed by FITC-Ficoll and albumin. Am J Physiol Renal Physiol 2000;279:F84–91.
  • Gao D, Xu H, Philbert MA, et al. Bioeliminable nanohydrogels for drug delivery. Nano Lett 2008;8:3320–4.
  • Donnelly RF, McCrudden MT, Alkilani AZ, et al. Hydrogel-forming microneedles prepared from “super swelling” polymers combined with lyophilised wafers for transdermal drug delivery. PLoS One 2014;9:e111547.
  • Donnelly RF, Mooney K, Mccrudden MT, et al. Hydrogel-forming microneedles increase in volume during swelling in skin, but skin barrier function recovery is unaffected. J Pharm Sci 2014;103:1478–86.
  • Yu J, Zhang Y, Ye Y, et al. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. Proc Natl Acad Sci USA 2015;112:8260–5.
  • Ye Y, Yu J, Wang C, et al. Microneedles integrated with pancreatic cells and synthetic glucose‐signal amplifiers for smart insulin delivery. Adv Mater 2016;28:3115–21.
  • Galvin O, Srivastava A, Carroll O, et al. A sustained release formulation of novel quininib-hyaluronan microneedles inhibits angiogenesis and retinal vascular permeability in vivo. J Control Release 2016;233:198–207.
  • Romanyuk AV, Zvezdin VN, Samant P, et al. Collection of analytes from microneedle patches. Anal Chem 2014;86:10520–3.
  • Caffarel-Salvador E, Brady AJ, Eltayib E, et al. Hydrogel-forming microneedle arrays allow detection of drugs and glucose in vivo: potential for use in diagnosis and therapeutic drug monitoring. PLoS One 2015;10:e0145644. doi: 10.1371/journal.pone.0145644. eCollection 2015.
  • Katsumi H, Liu S, Tanaka Y, et al. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats. J Pharm Sci 2012;101:3230–8.
  • Matsuo K, Yokota Y, Zhai Y, et al. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens. J Control Release 2012;161:10–17.
  • Zhu Z, Luo H, Lu W, et al. Rapidly dissolvable microneedle patches for transdermal delivery of exenatide. Pharm Res 2014;31:3348–60.
  • Lusky L and Nelson A. Fibrosarcomas induced by multiple subcutaneous injections of carboxymethylcellulose (CMC), polyvinylpyrrolidone (PVP), and polyoxyethylene sorbitan monostearate (Tween 60). In: Federation Proceedings; 1957. Bethesda, MD.
  • U.S. Department of Health and Human Services. Chondroitin sulfate – National Toxicology Program. Research Triangle Park, NC: US DHHS; 2009.
  • GE Healthcare Life Sciences. Biosciences A. Data file-dextra; dextran sulphate 10 sodium salt; 2001.
  • Satterthwaite RWIDSdWR, Bemiller JN. Industrial gums. New York: Academic Press; 1973:577–99.
  • Zhang Q, Yan S, Li M. Silk fibroin based porous materials. Materials 2009;2:2276–95.
  • Liu S, Jin M-N, Quan Y-S, et al. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin. Eur J Pharm Biopharm 2014;86:267–76.
  • Becker LC, Bergfeld WF, Belsito DV, et al. Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate. Int J Toxicol 2009;28:5–67.
  • Wohlrab J, Wohlrab D, Neubert RH. Comparison of noncross-linked and cross-linked hyaluronic acid with regard to efficacy of the proliferative activity of cutaneous fibroblasts and keratinocytes in vitro. J Cosmet Dermatol 2013;12:36–40.
  • Necas J, Bartosikova L, Brauner P, et al. Hyaluronic acid (hyaluronan): a review. Vet Med-Czech 2008;53:397–411.
  • Kenne L, Gohil S, Nilsson EM, et al. Modification and cross-linking parameters in hyaluronic acid hydrogels-definitions and analytical methods. Carbohydr Polym 2013;91:410–18.
  • Tezel A, Fredrickson GH. The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther 2008;10:35–42.
  • Raymond C, Rowe PJS, Quinn ME. Handbook of pharmaceutical excipients. Grayslake, IL: Pharmaceutical Press and the American Pharmacists Association; 2009:422–4.
  • Smyth HF, Carpenter CP, Weil CS. The toxicology of the polyethylene glycols. J Am Pharm Assoc 1950;39:349–54.
  • McCrudden MT, Alkilani AZ, Courtenay AJ, et al. Considerations in the sterile manufacture of polymeric microneedle arrays. Drug Deliv Transl Res 2015;5:3–14.
  • Martanto W, Moore JS, Couse T, et al. Mechanism of fluid infusion during microneedle insertion and retraction. J Control Release 2006;112:357–61.
  • Martanto W, Baisch SM, Costner EA, et al. Fluid dynamics in conically tapered microneedles. AIChE J 2005;51:1599–607.
  • Kim K, Park DS, Lu HM, et al. A tapered hollow metallic microneedle array using backside exposure of SU-8. J Micromech Microeng 2004;14:597.
  • Wang P-C, Paik S-J, Chen S, et al. Fabrication and characterization of polymer hollow microneedle array using UV lithography into micromolds. J Microelectromech Syst 2013;22:1041–53.
  • Lyon BJ, Aria AI, Gharib M. Fabrication of carbon nanotube-polyimide composite hollow microneedles for transdermal drug delivery. Biomed Microdev 2014;16:879–86.
  • Kwon KY, Weber A, Li W. Varying-length polymer microneedle arrays fabricated by droplet backside exposure. J Microelectromech Syst 2014;23:1272–80.
  • Hirakawa S, Ogai N, Wada Y, et al. An approach to fabricate the polymer hollow microneedle that targets dermal lymphatic vessels in the skin. J Dermatol Sci 2013;69:e28–9.
  • Lhernould MS, Deleers M, Delchambre A. Hollow polymer microneedles array resistance and insertion tests. Int J Pharm 2015;480:152–7.
  • Fartash B, Arvidson K. Long-term evaluation of single crystal sapphire implants as abutments in fixed prosthodontics. Clin Oral Implants Res 1997;8:58–67.
  • Parthasarathy K, Shen Y, Brabant K, et al. Biocompatibility of sapphire and borosilicate glass for neural prosthesis using MRI and histopathology. Proc Int Soc Mag Reson Med; 2006;14:1506.
  • Maibach HI, Menné T. Nickel and the skin: immunology and toxicology. Boca Raton, FL: CRC Press; 1989.
  • IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Surgical implants and other foreign bodies: IARC monographs on the evaluation of carcinogenic risks to humans. Lyon, France: IARC Press; 1999.
  • Santonen T, Stockmann-Juvala H, Zitting A. Review on toxicity of stainless steel. Helsinki, Finland: Finnish Institute of Occupational Health; 2010.
  • Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 2012;64:72–82.
  • Nemani KV, Moodie KL, Brennick JB, et al. In vitro and in vivo evaluation of SU-8 biocompatibility. Mater Sci Eng C Mater Biol Appl 2013;33:4453–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.